chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Tired; Soreness; This is a spontaneous report from a non-contactable consumer, the patient. A 67-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the arm right on 01Mar2021 at 14:30 (at the age of 67-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the arm right on 06Feb2021 at 15:00 as a single dose for COVID-19 immunisation. On 03Mar2021 at 12:00, the patient experienced tired and soreness. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events  tired and soreness was recovered on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
SWEATS; EXTREMELY SLEEPY; HUNGRY; CHILLS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced sweats, extremely sleepy, hungry, and chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the sweats, chills, extremely sleepy and hungry was not reported. This report was non-serious.
Information has been received from a physician concerning a pediatric patient with celiac disease who on unspecified date was vaccinated with the series of Hep B (manufacturer unknown) but was not seroconvert. It was unspecified if the patient sought medical attention. At the time of reporting the outcome of the patient was unknown. All telephone attempts to obtain follow-up information have been unsuccessful. This is one of several reports from the same source. Additional information has been requested.
3rd HIB given at 6 months - unnecessary to give 3rd dose at this age.
Within 3 minutes of the injection, I felt neck stiffness, then neck soreness. I felt a warm pressure sensation going up the base of my skull and over my head with pressure behind both eyeballs. After 48 hours of fever, chills, nausea, all body muscle aches, intense night sweating, a lymph node on the left side of base of  my skull became enlarged ,swollen, and painful. This lasted 48 hours. It took an entire week until side effects subsided.
Case number PHEH2014US02500, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 35 year old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 11 Nov 2014. The nurse reported that  FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The events reported after the maladministration.
Mom states patient had immunization yesterday and his arm is very swollen and hot. States child has a slight fever.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a 82-year-old female patient who received SHINGRIX (batch number ZG47A, expiry date 12th February 2021) for prophylaxis. On 26th July 2018, the patient received SHINGRIX. On 26th July 2018, less than a day after receiving SHINGRIX, the patient experienced injection site erythema, injection site tenderness and injection site warmth. The patient was treated with hydrocortisone. On an unknown date, the outcome of the injection site erythema, injection site tenderness and injection site warmth were unknown. It was unknown if the reporter considered the injection site erythema, injection site tenderness and injection site warmth to be related to SHINGRIX. Additional details were reported as follows: This case was previously reported to a physician. The patient received SHINGRIX on the left arm. The injection site was warm to touch. The patient was seen by a physician who treated with hydrocortisone cream. This case was one of the 3 cases, reported by the same reporter.
I would like to start out by saying I am a very healthy 21 year old. 10 minutes after shot was given my heart rate shot up to 150. Stayed up there for a couple minutes. I drank some water and it slowly went down.  About 45 minutes later I left the pharmacy and felt sick immediately. My ears clogged up and I couldn?t hear. For the next 2 days I had a fever and body aches. That eventually subsided but I still had ear and head fullness. I went to the doctor 3 days after I had the vaccine and they said I had a sinus infection and ear infection. Gave antibiotics but they did not help. After antibiotics were finished I was left with constant head pressure that wouldn?t go away. It?s like I?m constantly in a daze. It has been 2 months post shot and I still have intermittent head pressure and swollen lymph nodes. I also saw a cardiologist because I have been having heart issues ever since the shot. I am still waiting on my tests.
husband had chills and nausea after the first dose; husband had chills and nausea after the first dose; This is a spontaneous report from a contactable consumer (patient herself)  male patient of an unspecified age received first dose of bnt162b2  (PFIZER-BIONTECH COVID-19 Vaccine ,Formulation : Solution for injection)dose 1 via an unspecified route of administration on an unspecified date as SINGLE DOSE for covid-19 immunisation.The patient medical history was not reported.The patient's concomitant medications were not reported.The patient experienced husband had chills and nausea after the first dose (chills) , husband had chills and nausea after the first dose on an unspecified date and The events were considered as non-serious by the other healthcare professional. The outcome of the events was unknown.  No follow-up attempts are needed. No further information expected.
This spontaneous report as received from a nurse refers to unspecified patients of unknown age and gender. On an unknown date these unspecified patients were vaccinated with 5 doses of VARIVAX (Merck) (lot#, dose, route not reported) that had been improperly stored. No adverse effects were reported. This is one of several reports received from the same reporter (other MARRS # 1408USA006849). Additional information is not expected because the reporter did not want to be contacted.
Within 30 minutes post vax, the pt started repeated vomiting and continued such for 5 hours.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40-year-old male patient received BNT162b2 (BNT162B2), on 01Sep2022 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 39 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset May2023, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19. Patient was on Paxlovid treatment from 20May2023 to 24May2023.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Fainting; Red Palms; blotching; sweating profusely; heart palpitations; Chest pain; Elevated BP; This is a spontaneous report from a contactable consumer (patient). A 46-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 28Dec2020 09:15 at single dose on left arm (Lot number: ek9231) for COVID-19 immunisation. Medical history included asthma, bronchitis, mitral valve regurgitation, herpes, depression, ADHD. COVID prior vaccination: Yes. Known allergies: tramadol, milk products. No other vaccine in four weeks. Concomitant medication included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), bupropion, and, losartan/hydrochlorothiazide. The patient experienced red palms/blotching, sweating profusely, heart palpitations, chest pain and fainting, elevated BP, all on 28Dec2020 09:15. All these events required Emergency room visit. Therapeutic measures were taken as a result of the events included 50 mg of Benadryl, 60 mg of Prednisone, omepresol. No COVID tested post vaccination. Outcome of events was recovered with sequelae.
Right upper arm very tender, hot, red area around vaccine site  approx 10 X 10 cm.
acute unilateral parotitis on right side starting about 24 hours after vaccine tactile temperature
Redness, swelling & pain at site of injection approx 2" no fever or other symptoms.
12 hours after injection, I woke up to excruciating full body pain and nausea. The pain was easily an 8/10 and I was crying from the pain, shaking from chills, and could not get out of bed to the bathroom because the pain was so severe. I took 1000 mg of Tylenol which did not help at all. By 11 am, I began running a low grade fever and the pain felt unbearable. I took an old pain prescription for hydrocodone because I do not have insurance and cannot go to the doctor and the pain was not manageable. The hydrocodone brought the pain from a then 9/10 to a 6/10 and I was able to rest briefly before I woke up nauseous and began vomiting.  The pain was again at an 8/10 in my entire body and i was still running a low grade fever. It is now 4:46 pm and I am severely fatigued, nauseous, and in an unbearable amount of pain. I did not even get this sick when I had the flu 2 years ago. I now have an intense headache in addition to all other symptoms, and stomach pain and cramps. I am unable to keep even water down so I cannot even take Tylenol again. If I had someone who lived with me or I had insurance, I would be in urgent care right now.
Rec'd MENACTRA 2-21-11. On 2-22-11 patient stated he had fever 100 F, fatigue, decreased energy and injection site soreness. 2-23-11 States symptoms subsided except some tenderness at injection site.
Headache, low-grade fever, body aches, swollen lymph nodes on left side of neck, swollen lymph node in left arm pit (about walnut size), arthritis-type pain while squeezing left hand, and increased heart rate.
Experienced numbness; Pain through armpit and shoulder; Pain through armpit; Extreme fatigue for 7 days after injection; Left arm where vaccine was injected was extremely painful/ Pain through armpit and shoulder all the way to ring and pinky fingers on day 3 and 4; Limited mobility on day 1 and 2.; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Apr2021 at 11:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergy to red wine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 17Apr2021 at 16:00, the patient experienced extreme pain in  left arm where vaccine was injected was and had limited mobility on day 1 and 2 (17Apr2021-19Apr2021). The patient also experienced numbness and pain through armpit and shoulder all the way to ring and pinky fingers on day 3 and 4 (19Apr2021- 20Apr2021) and extreme fatigue for 7 days after injection. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of reported events which included treatment paracetamol (TYLENOL) and sleep. The clinical outcome of the events extreme fatigue was recovered on 24Apr2021, after the duration of 7 days. The clinical outcome of events left arm where vaccine was injected was extremely painful and had limited mobility on day 1 and 2, experienced numbness and pain through armpit and shoulder all the way to ring and pinky fingers on day 3 and 4 and extreme fatigue was recovering at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Autoimmune Encephalopahy - Weakness, confusion, delirium, tremors, monoclonal muscle spasms upper and lower extremities, inability to sleep, loss of coordination, loss of cognitive function, inability to control bowel or badder.
2nd dose of infant flu vaccine given to pt on 1/9/06. At 11 pm this  evening pt. developed "blank stare and face turned blue and felt hot." Pt taken to ER and Dx with acute febrile seizure. Tx with Motrin/Tylenol. Medical record states fever.
9/15/21 began experiencing sharp left side chest pain that would radiate up left shoulder and neck, accompanied with shortness of breath upon mild exertion. Was evaluated at the ER that night for pulmonary embolism and MI.  All test at hospital were normal. was referred to cardiologist and diagnosed with pericarditis on 9/29/21. symptoms began to improve on 9/28/21 and have resolved on 10/1/21.
Headache & Myalgia Narrative: Headache and sore arm. Took Tylenol.
Erythema and mild swelling 3 x 1.5 cm on the Rt deltoid area.
Her arm killed her and was painful for two days, she could barely move her arm; Her arm killed her and was painful for two days, she could barely move her arm; She also experienced numbness in her face, jaw, cheeks, mouth that lasted for about 3 hours; She also experienced numbness in her face, jaw, cheeks, mouth that lasted for about 3 hours; This is a spontaneous report from a contactable nurse. A 51-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EK5730), via an unspecified route of administration on 23Dec2020 at a single dose for COVID-19 immunization. Medical history included ongoing asthma for approximately 25 years ago. There were no concomitant medications. After she took the first dose, on an unknown date, her arm killed her and was painful for two days, she could barely move her arm. She also had numbness in her mouth, face, jaws, and cheeks that lasted about 3 hours. The outcome of the events was unknown.
This spontaneous report as received from a pharmacist refers to a 65 year old female patient. On 15-APR-2013, the patient was vaccinated with a dose of ZOSTAVAX (Lot number and expiry date were not reported), 0.65 milliliter (reported as standard dose), subcutaneously. On 16-APR-2013, the patient experienced redness, inflammation and swelling at the injection site that was the back of the arm and severe headache. The patient stated that the swelling was the size of a walnut yesterday and the pharmacist stated that the swelling was the size of the tennis ball at the time of this report. The patient sought medical attention and visited the pharmacist. BENADRYL was taken last night and the pharmacist had recommended ibuprofen and the patient had applied cool compress. The patient would be stopping by the physician office today. The outcome of redness, inflammation at the injection site and severe headache was unknown. The outcome of inflammation at the injection site was not recovered/resolved. Additional information has been requested.
Two minutes after receiving her vaccination, she experienced lightheadedness and the  syncopized for approximately 5 to 10 seconds. She was taken to a private section of the arena and monitored. Her blood pressure? was initially low with systolics in the 70s,, then increased to the 90s. Her heart rate range from 50 to 70s.
Pt described heart racing, pulse 114-130, says has POTS and this happens occassionally, 118/86, 97% RA, 18 EKG-NS
Headaches, muscle aches, fatigue  Both my husband and I had vaccines on the same day.  We both were exposed to covid on 5/9/2021 and both tested positive for covid.
HX of multiple myeloma, BMH, CKD 3; presented to ED after a fall at home with SOB and weakness, positive for COVID; acute hypoxemic respiratory failure due to COVID pneumonia
Approximately 6:00 p.m. the day to the vaccination I had a clenching chest pain around my heart or left breast.  The following morning when I woke up approximately 24 hours after my vaccination I had back pain located in my upper left back. It felt like it was behind my heart. It came and went throughout the entire day. The pain was so painful that it's knocked me to the ground and I felt like I could not move my upper body.
Severe headache beginning less than 24 hours after injection.  OTC medication (Excedrin) would temporarily alleviate symptoms.  Severe headache returned within a few hours.  Severe headache presented a total of four times (with temporary relief as described above).  Headache symptoms subsided on day 3 after the injection.  Intermittent muscle spams at the injection site (left arm) presented beginning approximately 4 or 5 days after the injection and persisted until day 7 after the injection.
1st dose on 2019, hadn´t received the 2nd; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 67-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 17th October 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.       Additional Information: GSK Receipt Date: 06-JAN-2023 Reporter's Comments: A pharmacist reported that a patient had not received the second dose of Shingrix.  The vaccine administration facility was the same as primary reporter. The reporter consented to follow up. VAERS details pertains to 1st dose of Shingrix in product tab.  Additional Supportive Information: Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.
Shingles; This is a spontaneous report from a contactable consumer (Patient). A 63-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot Number: EW0153), via an unspecified route of administration, administered in Arm Left on 05May2021 at 18:00 as dose 1, single (at the age of 63 years) for COVID-19 immunization. The patient medical history was not reported. Concomitant medication(s) included vitamins nos (VITAMINS NOS). Patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received Vitamins within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 10May2021 at 06:00 AM patient experienced Shingles. The patient received Famciclovir 500mg & Gabapentin 300mg as a treatment for event. The adverse event resulted in Doctor or other healthcare professional office/clinic visit. The outcome of event was recovering.  Follow-up attempts are completed. No further information is expected.
left palmar itching throat scratchy from 12:50-13:20 BP 146/93 HR 84 5 min post: BP 143/96, HR 84 10 min post:  BP 129/88, HR 76
Had fever last week and runny nose. Vesicles spread over trunk and limbs and face.
This case was reported by a other health professional via call center representative and described the occurrence of influenza-like symptoms in a 66-year-old female patient who received SHINGRIX for prophylaxis. The patient's past medical history included malaria. Concurrent medical conditions included cancer. On 6th July 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On an unknown date, several days after receiving SHINGRIX, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was recovered/resolved.  It was unknown if the reporter considered the influenza-like symptoms to be related to SHINGRIX. Additional details were reported as follows: This case was reported by a licensed clinical social worker, who was also the patient. The patient received SHINGRIX on the left arm. The patient stated that, a couple of days after receiving SHINGRIX, she experienced flu-like symptoms. The reporter did not consent to follow up.
Starting the evening after the injection, the injection site became sore and red and took about a week to resolve and go away. This is the second dose of SHINGRIX and the same reaction occurred with dose 1. A previous VAERS report was submitted, I called the manufacturer to get direction on whether to administer the second dose and they said if patient was willing, I should go ahead and inject the 2nd dose when the time came. I did and she had another reaction, similar to the first.
2 days after my second injection, I developed an annoying  cough. The cough is non productive, and is NOT accompanied by fever, nausea, vomiting, diarrhea, aches, chills or any other symptom.  i would liken this particular cough to the same side effect cough as to what one would possibly get from taking Lisinopril. Just an annoying cough. Currently there has been no treatment other than a possible follow-up with my PCP should symptom remain the same or get worse. The outcome is yet to be determined.
This case was reported by a healthcare professional via a sales representative and described the occurrence of hepatitis b test negative in an adult subject of unspecified gender who was vaccinated with hepatitis A inactivated and hepatitis B recombinant vaccine (TWINRIX, Glaxosmithkline). In 2008 the subject received the standard schedule of TWINRIX (unknown). In 2008, approximately six months after vaccination with the last dose of TWINRIX, the healthcare provider took titers and the subject did not show protective levels for hepatitis A, hepatitis B or both hepatitis A and B. Multiple subjects (approximately 17 - 18 subjects), who were sanitary workers were vaccinated during 2008 with the standard schedule of TWINRIX. Approximately six months after the last dose, the healthcare provider took titers and five subjects did not show protective levels for hepatitis Band six subjects did not show protective levels for hepatitis A. Some of these subjects showed non-protective titers for both A and B in the same subject. There were some vaccinated subjects in the group of 17-18 employees whose levels were "fine". Their local health department recommends that post-vaccination titers be done to prove protection.
Severe stomach pain, diarrhea for 48 hours, vomiting,  nausea,  severe headache. Also very sore arm.